Form 4: Pressure BioSciences CEO Acquires Shares Through Interest Payment

Richard T. Schumacher, President and CEO of Pressure BioSciences Inc, acquired 22,878 shares of common stock on September 27, 2024, through interest paid on convertible preferred stock.

Summary

• On September 27, 2024, Richard T. Schumacher, the President and CEO of Pressure BioSciences Inc, acquired 22,878 shares of common stock.
• The acquisition was a result of interest paid on convertible preferred stock.
• The price per share was $0.028.
• Following the transaction, Schumacher directly owns 82,967 shares.

Sentiment

Score: 6

Explanation: The sentiment is neutral. It's a routine filing related to interest payments in the form of shares. While insider ownership is generally positive, the method of acquisition is not a direct purchase on the open market.

Positives

• The CEO's acquisition of shares, even through interest payment, could be seen as a positive signal of confidence in the company.

Industry Context

Form 4 filings are standard practice and provide transparency into the transactions of company insiders, allowing investors to track ownership changes and potential alignment of interests.

Stakeholder Impact

• The transaction may have a minor positive impact on shareholder sentiment due to increased insider ownership.

Key Dates

Keywords

Pressure BioSciences Inc, PBIO, Richard T Schumacher, common stock, beneficial ownership, Form 4, interest payment, convertible preferred stock